Home  >  Products  >  FHL5 (four and a half LIM domains 5) Blocking Peptide (100ug)
FHL5 (four and a half LIM domains 5) Blocking Peptide (100ug)

FHL5 (four and a half LIM domains 5) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-FHL5 antibody (Catalogue #: ARP51673_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP51673
Size: 100 ug
Weight: 33kDa
Gene: 9457
Format: Lyophilized powder
Target: FHL5 is coordinately expressed with activator of cAMP-responsive element modulator (CREM). It is associated with CREM and confers a powerful transcriptional activation function. CREM acts as a transcription factor essential for the differentiation of spermatids into mature spermatozoa.The protein encoded by this gene is coordinately expressed with activator of cAMP-responsive element modulator (CREM). It is associated with CREM and confers a powerful transcriptional activation function. CREM acts as a transcription factor essential for the differentiation of spermatids into mature spermatozoa. There are multiple polyadenylation sites found in this gene. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: ACT; FLJ33049; KIAA0776; RP3-393D12.2; dJ393D12.2
See Full Product Listings >